Home
Resource
Role of autophagy in LKB1-deficient Kras-driven non-small cell lung cancer
PDF
PDF format is widely accepted and good for printing.
Plug-in required
PDF-1(45.81 MB)
Citation & Export
View Usage Statistics
Staff View

Citation & Export
Hide

Simple citation

Bhatt, Vrushank Dharmesh. Role of autophagy in LKB1-deficient Kras-driven non-small cell lung cancer. Retrieved from https://doi.org/doi:10.7282/t3-89ed-0n26

Export

Click here for information about Citation Management Tools at Rutgers.

Statistics
Hide

Description

TitleRole of autophagy in LKB1-deficient Kras-driven non-small cell lung cancer
NameBhatt, Vrushank Dharmesh (author); Guo, Jessie Yanxiang (chair); Zong, Wei-Xing (member); Ganesan, Shridar (member); White, Eileen (member); Guo, Jessie Yanxiang (member); Rutgers University; School of Graduate Studies
Date Created2021
Other Date2021-10 (degree)
SubjectOncology, Lungs -- Cancer, Autophagic vacuoles, Autophagy, Cancer, KRAS, LKB1, Metabolism, NSCLC, Non-small cell lung cancer
Extent1 online resource (viii, 113 pages) : illustrations
DescriptionTumor suppressor liver kinase B1 (LKB1) activates 5’-adenosine monophosphate protein kinase (AMPK) and maintains energy homeostasis in response to energy crises. LKB1 and KRAS are the third most frequent co-mutations detected in non-small cell lung cancer (NSCLC), causing aggressive tumor growth. Treatment with RAS-RAF-MEK-ERK pathway inhibitors have minimal therapeutic efficacy in LKB1-mutant Kras-driven NSCLC but can form the basis for lung cancer combination therapies.

Autophagy is a lysosomal-mediated self-cannibalization process that seizes, digests and metabolizes subcellular and macromolecules cellular organelles. We have previously reported that autophagy compensates for Lkb1 loss for Kras-driven lung tumorigenesis; loss of an autophagy essential gene Atg7 dramatically impaired tumor initiation and tumor growth in KrasG12D/+;Lkb1-/- (KL) lung tumors. This is in sharp contrast to Lkb1 wild-type (WT) (KrasG12D/+;p53-/- (KP)) tumors that are less sensitive to autophagy gene ablation. We further found that autophagy deficiency causes defective intracellular recycling, which limits amino acids (AAs) to support mitochondrial energy production in starved cancer cells and causes autophagy-deficient cells to be more dependent on fatty acid oxidation (FAO) for energy production, leading to reduced lipid reserve and energy crisis. Our findings strongly suggest that autophagy inhibition could be a strategy for treating LKB1-deficient lung tumors. However, targeting autophagy alone might be insufficient for the development of a potent cancer agent.

We designed the concept of using a combination therapy of autophagy together with MEK inhibition as a strategy to developing potent lung cancer agents. The combination therapy displays synergistic anti-proliferative effects in KL TDCLs, but not in KP TDCLs. Similarly, we found that LKB1-mutant human lung cancer cell lines were much more sensitive to the combination treatment than LKB1 WT cells. Treatment with ferroptosis inhibitor Ferrostatin-1 rescued the cell death induced by the combination treatment. Furthermore, in vivo studies using allograft mouse models and GEMMs showed anti-tumor synergistic effects of the combination treatment in KL tumor growth, with no such effect in KP tumor growth.

Taken together, our observations suggest that autophagy upregulation in Lkb1-deficient tumors cause resistance to Trametinib treatment by maintaining energy homeostasis and inhibiting ferroptosis to support KL cell survival. Therefore, a combination of autophagy and MEK inhibition could be a novel therapeutic strategy to specifically treat LKB1-deficient NSCLC.
NotePh.D.
NoteIncludes bibliographical references
Genretheses
Persistent URLhttps://doi.org/doi:10.7282/t3-89ed-0n26
LanguageEnglish
CollectionSchool of Graduate Studies Electronic Theses and Dissertations
Organization NameRutgers, The State University of New Jersey
RightsThe author owns the copyright to this work.
Version 8.5.5
Rutgers University Libraries - Copyright ©2024